Diabetic Patients Are At Risk For Developing Fournier's Gangrene Mistaken as The Ordinary Flesh-Eating Disease

Diabetes Drug Infection Lawsuit News

Little is known about Fournier's Gangrene and the disease is confused with necrotizing fasciitis, a common variety of flesh-eating disease

Monday, September 2, 2019 - Persons over 55 years of age and taking Invokana to treat Type-2 diabetes should be aware of the risks of contracting the painful and often deadly form of necrotizing fasciitis called Fournier's Gangrene. Cases of the more common flesh-eating disease are being brought to the attention of the public in the news every week as the symptoms are grotesque and seem incredibly painful. For example, a Florida man died the other day from what diagnosed as necrotizing fasciitis where twenty-five percent of his skin had to be removed in an attempt to stop the spread of rotting tissue. I suspect, however, that the Florida man many have succumbed Fournier's Gangrene, not just common necrotizing fasciitis as several factors point in that direction. Fournier Gangrene lawsuit attorneys represent families and individuals having suffered severe genital infections from diabetes drugs may be entitled to significant compensation for the harm and suffering they have experienced.

The victim's surviving wife gave an account that the streptococcus bacteria that cause necrotizing fasciitis may have entered his body through a cut on the victim's leg. She also mentioned that he had flu-like symptoms including aches, fever, groin and leg pain, according to Fox News. These are classic signs of Fournier's Gangrene. The conclusive piece of the diagnosis puzzle may be that the patient was diabetic and most likely taking SGLT2 inhibitor drugs that the Center for Disease Control (CDC), and US Food and Drug Administration (FDA) have linked to Fournier's Gangrene, the flesh-eating disease of the genitals. The Orlando Florida man underwent three operations that removed 25% of his skin. "She said five days later, when the symptoms got worse and her husband complained of extreme pain in his groin and leg, she rushed him to the emergency room," according to Fox.

Last year the FDA stated that it had identified 55 cases of Fournier's Gangrene, a form of necrotizing fasciitis particular to diabetic patients taking sodium-glucose inhibitor drugs to treat type 2 diabetes. Included in the warning was an instruction for certain drug companies to update drug warning labels, prescription information, and patient medical guides including their websites to warn of the flesh-eating disease risk. One drug that is included in the warning is Canagliflozin, a.k.a. Invokana, manufactured by Johnson & Johnson, a popular SGLT2 drug prescribed to treat Type 2 diabetes. Invokana (canagliflozin) is a sodium-glucose cotransporter-2 (SGLT2) inhibitor which redirects glucose directly to the urine to be expelled as waste. Invokana.com warns of the serious risks of amputation from Fournier's Gangrene.

A similar case of mistaken diagnosis may have occurred earlier this year when a retired military man under the care of a Florida nursing home died after a flesh-eating bacteria caused his penis to rot and eventually drop off. The many was a diabetic patient also and as such Fournier's Gangrene can not be ruled out. It is not known if the man's family or Florida health officials have made the connection between the diabetes drug the man was taking and his death from Fournier's Gangrene.

More Recent Diabetes Drug Infection Lawsuit News:

Lawyers for Fournier's Gangrene

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.